Bosh sahifaGLAXO • NSE
add
GlaxoSmithKline Pharmaceuticals Ltd
Yopilish kursi
2 583,80 ₹
Kunlik diapazon
2 584,00 ₹ - 2 584,00 ₹
Yillik diapazon
2 220,30 ₹ - 3 515,70 ₹
Bozor kapitalizatsiyasi
437,75 mlrd INR
Oʻrtacha hajm
74,23 ming
Narx/foyda
42,88
Dividend daromadliligi
1,63%
Asosiy maydon
NSE
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (INR) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 10,41 mlrd | 9,67% |
Joriy xarajat | 3,26 mlrd | 2,93% |
Sof foyda | 2,96 mlrd | 28,60% |
Sof foyda marjasi | 28,39 | 17,27% |
Har bir ulushga tushum | — | — |
EBITDA | 3,61 mlrd | 27,20% |
Amaldagi soliq stavkasi | 26,08% | — |
Balans
Jami aktivlari
Jami passivlari
| (INR) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 20,61 mlrd | -2,36% |
Jami aktivlari | — | — |
Jami passivlari | — | — |
Umumiy kapital | 17,08 mlrd | — |
Tarqatilgan aksiyalar | 169,41 mln | — |
Narxi/balansdagi bahosi | 25,63 | — |
Aktivlardan daromad | — | — |
Kapitaldan daromad | 50,34% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (INR) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 2,96 mlrd | 28,60% |
Operatsiyalardan naqd pul | — | — |
Sarmoyadan naqd pul | — | — |
Moliyadan naqd pul | — | — |
Naqd pulning sof oʻzgarishi | — | — |
Boʻsh pul | — | — |
Haqida
GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease, and respiratory diseases. It also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, and others. Wikipedia
Tashkil etilgan
13-noy, 1924
Xodimlar soni
3 113
